CVKD News

Latest breaking news and updates for CVKD stock.

Track all markets on TradingView

Cadrenal Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

PONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #AFib--Cadrenal Therapeutics reports on Second Quarter 2025 financial results and provides corporate update on strategic clinical trial plans.

Are there any forward-looking guidance revisions or new guidance provided for Q3 2025 and beyond? What is the expected impact of any partnership or licensing agreements mentioned in the update on the company's growth prospects? How might the company's cash runway and capital allocation strategy impact its ability to fund ongoing and future trials?
Earnings
14 days ago
Read more businesswire

Cadrenal Therapeutics Announces Clinical Trial Initiation Plans for Tecarfarin in Patients with End-Stage Kidney Disease (ESKD) Transitioning to Dialysis

PONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #AFib--Cadrenal announces clinical trial initiation plans for tecarfarin in patients with end-stage kidney disease (ESKD) who are transitioning to dialysis

How does the expected cost of the trial compare to previous clinical programs run by Cadrenal? Will the company’s cash runway be sufficient to fund the trial without diluting existing shareholders? What is the potential competitive landscape if Tecarfarin reaches the market—who are the main rivals?
Clinical trials
20 days ago
Read more businesswire